Hypertension (high blood pressure) Board decisions

The Board denied service connection for diabetes mellitus and remanded the claims for service connection for hypertension and stroke, as further evidence is needed to determine their etiology.

The Board remands the claims for service connection for diabetes mellitus, type II and hypertension due to a failure to substantially comply with prior remand directives.

The Board denied the claim for service connection for gout and remanded the claims for service connection for type II diabetes mellitus, amputation of left leg, right lower extremity neuropathy, bilateral upper extremity neuropathy, hypertension, a vision disorder, tremors, and gout, for additional development.

The Board denied a compensable rating for hypertension and granted a 70 percent disability rating for PTSD prior to January 17, 2024, while denying an increased rating on and after that date. The issues related to the lumbar strain and GERD were remanded.

The Board denied service connection for hypertension as the condition did not have its onset during active duty and there was no evidence of an increase in severity during the Veteran's last period of service.

The Board granted service connection for hypertension and rheumatoid arthritis, effective August 10, 2024.

The Board remands the claim for service connection for hypertension to obtain an addendum opinion that addresses the Veteran's assertions and provides a reasoned medical explanation.

The Board remands the claims for service connection for obstructive sleep apnea, headaches, dizziness, and hypertension to correct duty to assist errors that occurred prior to the rating decision on appeal.

The Board denied service connection for chronic fatigue syndrome and hypertension, but remanded claims for a left knee disorder, cervical spine disorder, left-hand disorder, and left wrist disorder.

The Board denied service connection for aortic valve disease, ischemic heart disease (IHD), and hypertension as the evidence did not support a finding that these conditions began during or are related to active service. The claims for squamous cell carcinoma, chloracne, and chronic inflammatory demyelinating polyneuropathy were remanded for further development.

The Board denied the Veteran's appeals to reopen claims for service connection for diabetes mellitus, hypertension, right and left lower extremity peripheral neuropathy, and remanded the claim for service connection for prostate cancer.

The Board granted service connection for hypertension under the PACT Act and denied service connection for PTSD, left ear hearing loss, and remanded claims for asthma, low back, neck condition, and tension headaches.

The Board denied the veteran's appeal for an earlier effective date for service connection for hypertension and arteriosclerotic heart disease with valvular heart disease, atrioventricular block, and heart palpitations.

The Board denied the Veteran's claim for a compensable rating for hypertension as there was no evidence of diastolic blood pressure predominantly 100 or more, systolic blood pressure predominantly 160 or more, or a history of such that required continuous medication.

The Board granted a disability rating of 10 percent, but no higher, for service-connected hypertension and denied an earlier effective date prior to August 10, 2022.

The Board granted an earlier effective date of June 28, 2024 for the grant of service connection for kidney disease and hypertension.

The Board granted service connection for tinnitus but denied it for hearing loss. The claims for headaches, hypertension, and an acquired psychiatric disability were remanded.

The Board remands the appeal for a medical opinion to determine if the Veteran's hypertension is related to toxic exposure risk activity during service.

The Board denied an increased evaluation for right knee scars and remanded several other claims, including service connection for hypertension, left hip condition, right hip condition, sleep apnea, and a TDIU.

The Board granted service connection for hypertension, as due to herbicide agent exposure on a presumptive basis.